Dysmyelinating and demyelinating conditions in infancy

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Myelin sheath is crucial for rapid nerve impulse conduction in the central nervous system.
• Dysmyelination, a failure in myelin formation, can result from various underlying causes.
• Understanding these causes is vital for diagnosing and managing neurological disorders.

Purpose of the Study:

• To categorize the diverse mechanisms leading to dysmyelination.
• To highlight specific genetic and metabolic disorders associated with myelin defects.
• To review conditions characterized by demyelination and malformation syndromes.

Main Methods:

• Literature review and synthesis of existing research on myelin disorders.
• Categorization of dysmyelination based on underlying pathology (synthesis defects, metabolic, demyelination, malformation).
• Identification of key genetic and acquired conditions associated with myelin abnormalities.

Main Results:

• Dysmyelination arises from defective myelin protein synthesis (e.g., Pelizaeus-Merzbacher disease).
• Inherited metabolic diseases (e.g., galactosemia) cause delayed myelination and white matter reduction.
• Demyelination is observed in leukodystrophies (e.g., Krabbe disease, multiple sclerosis) and HIV.
• Malformation syndromes (e.g., Cockayne syndrome) also involve myelin abnormalities.

Conclusions:

• Dysmyelination encompasses a spectrum of disorders with diverse etiologies.
• Neuroimaging plays a critical role in diagnosing leukodystrophies.
• Some myelin disorders are treatable, emphasizing the importance of accurate diagnosis.